Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Sheng

Showing results (391-400 of 669) with videos related to

Pageof 67
Sort By:
Translational Neurodegeneration|December 19, 2024
CD2AP deficiency aggravates Alzheimer's disease phenotypes and pathology through p38 MAPK activationYan-Yan Xue, Zhe-Sheng Zhang, Rong-Rong Lin, et al.
Frontiers in Pharmacology|October 26, 2018
Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer CellsWei Zhang, Ying-Fang Fan, Chao-Yun Cai, et al.
Biochemical Pharmacology|March 15, 2012
GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2- and ABCB1-mediated drug resistanceKamlesh Sodani, Amit K Tiwari, Satyakam Singh, et al.
Molecular Cancer|February 9, 2022
PBK/TOPK inhibitor OTS964 resistance is mediated by ABCB1-dependent transport function in cancer: in vitro and in vivo studyYuqi Yang, Qiu-Xu Teng, Zhuo-Xun Wu, et al.
Pharmacological Research|April 30, 2017
Suppression of ABCG2 mediated MDR in vitro and in vivo by a novel inhibitor of ABCG2 drug transportAtish Patel, Tian-Wen Li, Nagaraju Anreddy, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 31, 2024
Research progress on gene mutations and drug resistance in leukemiaXiangyu Ma, Jiamin Xu, Yanan Wang, et al.
Frontiers in Pharmacology|September 22, 2022
Jiyuan oridonin A induces differentiation of acute myeloid leukemia cells including leukemic stem-like cellsFahui Li, Congying Gao, Xueming Li, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 1, 2019
Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistanceSilpa Narayanan, Chao-Yun Cai, Yehuda G Assaraf, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 5, 2020
Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An updateJinyun Dong, Zuodong Qin, Wei-Dong Zhang, et al.
Cancer Letters|April 22, 2023
A multi-functional nano-system combining PI3K-110α/β inhibitor overcomes P-glycoprotein mediated MDR and improves anti-cancer efficiencyRuikun Lin, Lei Zhang, Biwei Ye, et al.
Pageof 67

Showing results (391-400 of 669) with videos related to

Sort By:
Pageof 67
Translational Neurodegeneration|December 19, 2024
CD2AP deficiency aggravates Alzheimer's disease phenotypes and pathology through p38 MAPK activationYan-Yan Xue, Zhe-Sheng Zhang, Rong-Rong Lin, et al.
Frontiers in Pharmacology|October 26, 2018
Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer CellsWei Zhang, Ying-Fang Fan, Chao-Yun Cai, et al.
Biochemical Pharmacology|March 15, 2012
GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2- and ABCB1-mediated drug resistanceKamlesh Sodani, Amit K Tiwari, Satyakam Singh, et al.
Molecular Cancer|February 9, 2022
PBK/TOPK inhibitor OTS964 resistance is mediated by ABCB1-dependent transport function in cancer: in vitro and in vivo studyYuqi Yang, Qiu-Xu Teng, Zhuo-Xun Wu, et al.
Pharmacological Research|April 30, 2017
Suppression of ABCG2 mediated MDR in vitro and in vivo by a novel inhibitor of ABCG2 drug transportAtish Patel, Tian-Wen Li, Nagaraju Anreddy, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 31, 2024
Research progress on gene mutations and drug resistance in leukemiaXiangyu Ma, Jiamin Xu, Yanan Wang, et al.
Frontiers in Pharmacology|September 22, 2022
Jiyuan oridonin A induces differentiation of acute myeloid leukemia cells including leukemic stem-like cellsFahui Li, Congying Gao, Xueming Li, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 1, 2019
Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistanceSilpa Narayanan, Chao-Yun Cai, Yehuda G Assaraf, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 5, 2020
Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An updateJinyun Dong, Zuodong Qin, Wei-Dong Zhang, et al.
Cancer Letters|April 22, 2023
A multi-functional nano-system combining PI3K-110α/β inhibitor overcomes P-glycoprotein mediated MDR and improves anti-cancer efficiencyRuikun Lin, Lei Zhang, Biwei Ye, et al.
Pageof 67